CLOMIPRAMINE HYDROCHLORIDE
CLOMIPRAMINE HYDROCHLORIDE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: CLOMIPRAMINE HYDROCHLORIDE; Generic name: CLOMIPRAMINE HYDROCHLORIDE; Manufacturer: Micro Labs Limited.
| Brand name | CLOMIPRAMINE HYDROCHLORIDE |
|---|---|
| Generic name | CLOMIPRAMINE HYDROCHLORIDE |
| Manufacturer | Micro Labs Limited |
| Used for | INDICATIONS AND USAGE Clomipramine hydrochloride capsules, USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning, in order to meet the DSM-III-R (circa 1989) diagnosis of OCD. Obsessions are recurrent, persistent ideas, thoughts, images, or impulses that are ego-dystonic. Compulsions are repetitive, purposeful, and intentional behaviors performed in response to an obsession or in a stereotyped fashion, and are recognized by the person as excessive or unreasonable. The effectiveness of |
| Dosage | DOSAGE AND ADMINISTRATION The treatment regimens described below are based on those used in controlled clinical trials of clomipramine hydrochloride capsules, USP in 520 adults, and 91 children and adolescents with OCD. During initial titration, clomipramine hydrochloride capsules, USP should be given in divided doses with meals to reduce gastrointestinal side effects. The goal of this initial titration phase is to minimize side effects by permitting tolerance to side effects to develop or allow |
| Warnings | WARNINGS Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are t |
| Active ingredient(s) | CLOMIPRAMINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bbee292-0fba-4606-9c8e-4723742682c0 |